Clinical trial participants to get digital vaccination certificates

ICMR was designated by the Union Health Ministry as the nodal agency for collection of vaccination data for such participants

August 23, 2021 07:29 pm | Updated 07:29 pm IST - NEW DELHI

Union Health Minister Mansukh Mandaviya.

Union Health Minister Mansukh Mandaviya.

Digital COVID-19 vaccination certificates will now be issued to the clinical trial participants of Covishield and Covaxin through Co-WIN, tweeted Health Minister Mansukh Mandaviya on Monday.

The Minister added that the nation “thanks them (trial participants) for their incredible commitment & contribution to COVID-19 vaccine research & treatment.”

He said participants can download their individual certificates through Co-WIN Portal, Aarogya Setu, Digilocker or the UMANG application.

The Union Health Ministry in its release noted that Indian Council of Medical Research (ICMR) in partnership with Serum Institute of India (SII) had conducted phase II/III bridging studies of Covishield from August 2020.

Phase III efficacy clinical trials for Covaxin were also conducted by Bharat Biotech International Limited from November 2020.

“The Union Ministry of Health and Family Welfare (MoHFW) had received several requests from the trial participants for digital vaccination certificates through Co-WIN,” said the release.

It added that a decision was taken that vaccination certificates may be issued to such participants who were administered the vaccines during these trials/studies, after the trials/studies were unblinded.

ICMR was designated by the Union Health Ministry as the nodal agency for collection of vaccination data for such participants.

ICMR had provided the data for 11,349 such persons to the MoHFW. Digital vaccination certificates will now be issued through Co-WIN, to such persons who participated in these studies/trials.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.